Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months

Pediatrics International

Volumn 46, Issue 2, 2004, Pages 122-125

  Maeda, Taro ^a   Shintani, Yukihiro ^b   Nakano, Kanako ^b   Terashima, Kazuhiro ^b   Yamada, Yoshiyasu ^b  

^a Department of Pediatrics   (Japan)

^b Konan Hospital Foundation Rokko Island Hospital   (Japan)

Author keywords

Children; Infant; Influenza; Vaccine

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INFANT; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; SEASONAL VARIATION; STATISTICAL ANALYSIS;

CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; TREATMENT FAILURE; VACCINES, INACTIVATED;

EID: 1942486325     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.2004.01852.x     Document Type: Article

References (15)

1. Advisory Committee on Immunization Practice (ACIP). Prevention and control of influenza: recommendations of Advisory Committee on Immunization Practice (ACIP). MMWR Morb. Mortal. Wkly Rep. 2002; 51(RR03): 1-31.
2. Hirota Y, Fedson DS, Kaji M. Japan lagging in influenza jabs. Nature 1996; 380: 18.
3. Yamamoto M, Matsuda M, Minamidani M et al. Questionnaire on effectiveness of immunization among Tokyo Pediatricians Society. Nippon Iji Shimpo 1990; 3442: 47-50 (in Japanese).
4. Togashi T, Matsuzono Y, Narita M. Epidemiology of influenza-associated encephalitis-encephalopathy in Hokkaido, the northernmost island of Japan. Pediatr. Int. 2000; 42: 192-6.
5. Togashi T, Matsuzono Y, Anakura M, Nerome K. Acute encephalitis and encephalopathy at the hight of influenza in children. Nippon Rinshou 1977; 55: 2699-705 (in Japanese).
6. Neuzil KM, Meilen BG, Wright PF et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N. Engl. J. Med. 2000; 342: 225-31.
7. Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N. Engl. J. Med. 2000; 342: 232-9.
8. Maeda T, Shintani Y, Miyamoto H et al. Prophylactic effect of inactivated influenza vaccine on young children. Pediatr. Int. 2000; 44: 43-6.
9. Fisher RG, Gruber WC, Edwards KM et al. Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. Pediatrics 1997; 99: E7.
10. Glezen WP. Morbidity associated with the major respiratory viruses. Pediatr. Ann. 1990; 19: 535-40.
11. Waner JL, Todd SJ, Shalaby H, Murphy P, Wall LV. Comparison of directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus. J. Clin. Microbiol. 1991; 29: 479-82.
12. Groothuis JR, Levin MJ, Rabalais GP et al. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991; 87: 823-8.
13. Mbawuike IN, Piedra PA, Cate TR, Couch RB. Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine. J. Med. Virol. 1996; 50: 105-11.
14. Govaert TM, Thijis CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. JAMA 1994; 272: 1661-5.
15. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 1994; 22: 778-84.